Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06800092
PHASE2/PHASE3
Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment
Sponsor: The University of Texas Medical Branch, Galveston
View on ClinicalTrials.gov
Summary
This study is examining the effects of standard of care cancer treatment as well as a medication called Sildenafil, on the cancer associated fatigue, cognition and the gut microbiome.
Key Details
Gender
FEMALE
Age Range
30 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-03-15
Completion Date
2030-06-01
Last Updated
2025-11-19
Healthy Volunteers
No
Conditions
Interventions
DRUG
Sildenafil
Sildenafil, 50mg, daily
Locations (1)
The University of Texas Medical Branch
Galveston, Texas, United States